A citation-based method for searching scientific literature

Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia.
Andrea de Bartolomeis, Camilla Avagliano, Licia Vellucci, Luigi D'Ambrosio, Mirko Manchia, Giordano D'Urso, Elisabetta Filomena Buonaguro, Felice Iasevoli. Neurosci Biobehav Rev 2019
Times Cited: 12






Login to export Results
Don't have an account? Register here

List of co-cited articles
193 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia.
Andrea de Bartolomeis, Mirko Manchia, Federica Marmo, Licia Vellucci, Felice Iasevoli, Annarita Barone. Front Psychiatry 2020
14
5
41

Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment.
Andrea de Bartolomeis, Felice Iasevoli, Federica Marmo, Elisabetta F Buonaguro, Anna Eramo, Rodolfo Rossi, Livia Avvisati, Gianmarco Latte, Carmine Tomasetti. Eur Neuropsychopharmacol 2015
19
4
33

Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
Arsime Demjaha, Robin M Murray, Philip K McGuire, Shitij Kapur, Oliver D Howes. Am J Psychiatry 2012
231
4
33

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Oliver D Howes, Rob McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J M van Beveren, Michael L Birnbaum, Michael A P Bloomfield, Rodrigo A Bressan, Robert W Buchanan, William T Carpenter,[...]. Am J Psychiatry 2017
431
4
33

Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
Ryosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda, Eric Plitman, Shiori Honda, Karin Matsushita, Sofia Chavez, Kyosuke Sawada, Masataka Wada, Mie Matsui,[...]. Neuropsychopharmacology 2020
24
4
33

Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis.
Annarita Barone, Simona Signoriello, Gianmarco Latte, Licia Vellucci, Giuseppe Giordano, Camilla Avagliano, Elisabetta F Buonaguro, Federica Marmo, Carmine Tomasetti, Felice Iasevoli,[...]. Behav Brain Res 2021
6
4
66

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
Andrea de Bartolomeis, Chiara Sarappa, Elisabetta F Buonaguro, Federica Marmo, Anna Eramo, Carmine Tomasetti, Felice Iasevoli. Prog Neuropsychopharmacol Biol Psychiatry 2013
53
4
33

Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions.
Carmine Tomasetti, Felice Iasevoli, Elisabetta Filomena Buonaguro, Domenico De Berardis, Michele Fornaro, Annastasia Lucia Carmela Fiengo, Giovanni Martinotti, Laura Orsolini, Alessandro Valchera, Massimo Di Giannantonio,[...]. Int J Mol Sci 2017
40
4
33

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.
Steven G Potkin, John M Kane, Christoph U Correll, Jean-Pierre Lindenmayer, Ofer Agid, Stephen R Marder, Mark Olfson, Oliver D Howes. NPJ Schizophr 2020
95
4
33

Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways.
. Nat Neurosci 2015
509
3
25

Dopamine receptor subtypes contribution to Homer1a induction: insights into antipsychotic molecular action.
Felice Iasevoli, Carmine Tomasetti, Alberto Ambesi-Impiombato, Giovanni Muscettola, Andrea de Bartolomeis. Prog Neuropsychopharmacol Biol Psychiatry 2009
37
3
25

Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function.
Kevin D Lominac, Erik B Oleson, Matthew Pava, Matthias Klugmann, Martin K Schwarz, Peter H Seeburg, Matthew J During, Paul F Worley, Peter W Kalivas, Karen K Szumlinski. J Neurosci 2005
99
3
25

Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole.
Felice Iasevoli, Carmine Tomasetti, Federica Marmo, Daniele Bravi, Jørn Arnt, Andrea de Bartolomeis. Psychopharmacology (Berl) 2010
40
3
25

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia.
Davide Amato, Anna Kruyer, Anne-Noël Samaha, Andreas Heinz. Front Psychiatry 2019
25
3
25

Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action.
C Tomasetti, C Dell'Aversano, F Iasevoli, A de Bartolomeis. Neuroscience 2007
38
3
25

Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain.
Alberto Ambesi-Impiombato, Fabio Panariello, Carmela Dell'aversano, Carmine Tomasetti, Giovanni Muscettola, Andrea de Bartolomeis. Synapse 2007
33
3
25

Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.
Arsime Demjaha, Alice Egerton, Robin M Murray, Shitij Kapur, Oliver D Howes, James M Stone, Philip K McGuire. Biol Psychiatry 2014
209
3
25

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Elias Mouchlianitis, Michael A P Bloomfield, Vincent Law, Katherine Beck, Sudhakar Selvaraj, Naresh Rasquinha, Adam Waldman, Federico E Turkheimer, Alice Egerton, James Stone,[...]. Schizophr Bull 2016
121
3
25

Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
Felice Iasevoli, Sara Giordano, Raffaele Balletta, Gianmarco Latte, Maria Vittoria Formato, Emiliano Prinzivalli, Domenico De Berardis, Carmine Tomasetti, Andrea de Bartolomeis. Prog Neuropsychopharmacol Biol Psychiatry 2016
77
3
25

Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
Andrea de Bartolomeis, Raffaele Balletta, Sara Giordano, Elisabetta Filomena Buonaguro, Gianmarco Latte, Felice Iasevoli. Psychiatry Res 2013
52
3
25

Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study.
Euitae Kim, Oliver D Howes, Mattia Veronese, Katherine Beck, Seongho Seo, Jin Woo Park, Jae Sung Lee, Yun-Sang Lee, Jun Soo Kwon. Neuropsychopharmacology 2017
70
3
25

A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter.
Davide Amato, Fabio Canneva, Paul Cumming, Simone Maschauer, Dominik Groos, Jana Katharina Dahlmanns, Teja W Grömer, Lisa Chiofalo, Marc Dahlmanns, Fang Zheng,[...]. Mol Psychiatry 2020
35
3
25

White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study.
Giulia Tronchin, Genevieve McPhilemy, Mohamed Ahmed, Liam Kilmartin, Laura Costello, Natalie J Forde, Leila Nabulsi, Theophilus N Akudjedu, Laurena Holleran, Brian Hallahan,[...]. Psychiatry Res 2021
4
3
75

Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.
Stephen K Brannan, Sharon Sawchak, Andrew C Miller, Jeffrey A Lieberman, Steven M Paul, Alan Breier. N Engl J Med 2021
50
3
25

Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine.
Manabu Takaki, Masafumi Kodama, Yutaka Mizuki, Hiroki Kawai, Bunta Yoshimura, Makiko Kishimoto, Shinji Sakamoto, Yuko Okahisa, Norihito Yamada. Eur Neuropsychopharmacol 2018
11
3
27

From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.
Bita Moghaddam, Daniel Javitt. Neuropsychopharmacology 2012
604
3
25

Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes.
Felice Iasevoli, Alberto Ambesi-Impiombato, Germano Fiore, Fabio Panariello, Giovanni Muscettola, Andrea de Bartolomeis. J Psychopharmacol 2011
34
3
25

The dopamine hypothesis of schizophrenia: version III--the final common pathway.
Oliver D Howes, Shitij Kapur. Schizophr Bull 2009
1533
3
25

Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.
Andrea de Bartolomeis, Gianmarco Latte, Carmine Tomasetti, Felice Iasevoli. Mol Neurobiol 2014
87
3
25

Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine.
Daniela Polese, Antonella Amato de Serpis, Alberto Ambesi-Impiombato, Giovanni Muscettola, Andrea de Bartolomeis. Neuropsychopharmacology 2002
59
3
25

NMDA receptor hypofunction model of schizophrenia.
J W Olney, J W Newcomer, N B Farber. J Psychiatr Res 1999
718
3
25

Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial.
Chieh-Hsin Lin, Ching-Hua Lin, Yue-Cune Chang, Yu-Jhen Huang, Po-Wei Chen, Hui-Ting Yang, Hsien-Yuan Lane. Biol Psychiatry 2018
65
3
25

Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients.
Marta Matrone, Georgios D Kotzalidis, Andrea Romano, Alessandro Bozzao, Ilaria Cuomo, Francesca Valente, Chiara Gabaglio, Ginevra Lombardozzi, Giada Trovini, Emanuela Amici,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2022
5
3
60

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS).
Bruce J Kinon. Front Psychiatry 2019
16
2
16

Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View.
Cheryl Cheuk-Yan Leung, Romayne Gadelrab, Chukwuma Uchenna Ntephe, Philip K McGuire, Arsime Demjaha. Front Psychiatry 2019
11
2
18

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
P Fusar-Poli, R Smieskova, M J Kempton, B C Ho, N C Andreasen, S Borgwardt. Neurosci Biobehav Rev 2013
332
2
16

Functional neuroimaging in treatment resistant schizophrenia: A systematic review.
Cinzia Molent, Daniele Olivo, Robert Christian Wolf, Matteo Balestrieri, Fabio Sambataro. Neurosci Biobehav Rev 2019
13
2
16

Homer proteins: implications for neuropsychiatric disorders.
Karen K Szumlinski, Peter W Kalivas, Paul F Worley. Curr Opin Neurobiol 2006
135
2
16

Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.
Jennifer A Hadley, Rodolphe Nenert, Nina V Kraguljac, Mark S Bolding, David M White, Frank M Skidmore, Kristina M Visscher, Adrienne C Lahti. Neuropsychopharmacology 2014
117
2
16

The postsynaptic architecture of excitatory synapses: a more quantitative view.
Morgan Sheng, Casper C Hoogenraad. Annu Rev Biochem 2007
667
2
16

The Homer family proteins.
Yoko Shiraishi-Yamaguchi, Teiichi Furuichi. Genome Biol 2007
224
2
16

Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory.
Jennifer Ann Hadley, Nina Vanessa Kraguljac, David Matthew White, Lawrence Ver Hoef, Janell Tabora, Adrienne Carol Lahti. NPJ Schizophr 2016
62
2
16

Changes in brain functional connectivity after chronic haloperidol in rats: a network analysis.
Anne L Wheeler, Meaghan C Creed, Aristotle N Voineskos, José N Nobrega. Int J Neuropsychopharmacol 2014
13
2
16

The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted.
Felice Iasevoli, Elisabetta Filomena Buonaguro, Camilla Avagliano, Annarita Barone, Anna Eramo, Licia Vellucci, Andrea de Bartolomeis. Int J Mol Sci 2020
4
2
50

Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, V Mondelli, T Reis Marques, C Pariante, P Dazzan,[...]. Psychol Med 2016
152
2
16

Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases.
Felice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis. Neurochem Res 2013
54
2
16

Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.
João M N Duarte, Lijing Xin. Neurochem Res 2019
25
2
16

Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs.
Felice Iasevoli, Camilla Avagliano, Benedetta Altavilla, Annarita Barone, Luigi D'Ambrosio, Marta Matrone, Danilo Notar Francesco, Eugenio Razzino, Andrea de Bartolomeis. Front Psychiatry 2018
17
2
16

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
A Demjaha, J M Lappin, D Stahl, M X Patel, J H MacCabe, O D Howes, M Heslin, U A Reininghaus, K Donoghue, B Lomas,[...]. Psychol Med 2017
135
2
16

Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.
Meghan Elizabeth Goldstein, Valerie Margaret Anderson, Avinesh Pillai, Robert R Kydd, Bruce R Russell. Int J Neuropsychopharmacol 2015
64
2
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy